Pulmonary veno-occlusive disease following reduced-intensity allogeneic bone marrow transplantation for acute myeloid leukemia

Internal Medicine

Volumn 51, Issue 2, 2012, Pages 195-198

  Hosokawa, Kohei ^a   Yamazaki, Hirohito ^a   Nishitsuji, Masaru ^a   Kobayashi, Satoshi ^b   Takami, Akiyoshi ^a   Fujimura, Masaki ^a   Nakao, Shinji ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myeloid leukemia; Gemtuzumab ozogamicin; Pulmonary; Reducedintensity transplantation; Veno occlusive disease

Indexed keywords

FLUDARABINE; GEMTUZUMAB OZOGAMICIN; MELPHALAN; PREDNISOLONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANEMIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DEATH; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYPOXEMIA; LUNG DIFFUSION CAPACITY; MALE; OXYGEN THERAPY; PULMONARY VENO-OCCLUSIVE DISEASE; REDUCED INTENSITY CONDITIONING; THROMBOCYTOPENIA; UNCONSCIOUSNESS; WHOLE BODY RADIATION;

BONE MARROW TRANSPLANTATION; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; PULMONARY VENO-OCCLUSIVE DISEASE; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 84856013312     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.6302     Document Type: Article

References (16)

1. Mandel J, Mark EJ, Hales CA. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med 162: 1964-1973, 2000.
2. Troussard X, Bernaudin JF, Cordonnier C, et al. Pulmonary venoocclusive disease after bone marrow transplantation. Thorax 39: 956-957, 1984.
3. Mukai M, Kondo M, Bohgaki T, Notoya A, Kohno M. Pulmonary veno-occlusive disease following allogeneic peripheral blood stem cell transplantation for chronic myeloid leukaemia. Br J Haematol 123: 1, 2003.
4. Johnson SR, Patsios D, Hwang DM, Granton JT. Pulmonary venoocclusive disease and scleroderma associated pulmonary hypertension. J Rheumatol 33: 2347-2350, 2006.
5. Thibeault R, Champagne M, de Repentigny L, et al. Fatal disseminated Trichosporon asahii infection in a child with acute lymphoblastic leukemia. Can J Infect Dis Med Microbiol 19: 203-205, 2008.
6. Antachopoulos C, Papakonstantinou E, Dotis J, et al. Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole. J Pediatr Hematol Oncol 27: 283-285, 2005.
7. Matsue K, Uryu H, Koseki M, Asada N, Takeuchi M. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin Infect Dis 42: 753-757, 2006.
8. Bornhauser M, Illmer T, Oelschlaegel U, et al. Gemtuzumab ozogamicin as part of reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with relapsed acute myeloid leukemia. Clin Cancer Res 14: 5585-5593, 2008.
9. de Lima M, Champlin RE, Thall PF, et al. Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome. Leukemia 22: 258-264, 2008.
10. Bunte MC, Patnaik MM, Pritzker MR, Burns LJ. Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction. Bone Marrow Transplant 41: 677-686, 2008.
11. Shahab N, Haider S, Doll DC. Vascular toxicity of antineoplastic agents. Semin Oncol 33: 121-138, 2006.
12. Takatsuka H, Wakae T, Mori A, Okada M, Okamoto T, Kakishita E. Effects of total body irradiation on the vascular endothelium. Clin Transplant 16: 374-377, 2002.
13. Wadleigh M, Richardson PG, Zahrieh D, et al. Prior gemtuzumab ozogamicin exposure significantly increases the risk of venoocclusive disease in patients who undergo myeloablative allogeneic stem cell transplantation. Blood 102: 1578-1582, 2003.
14. Gutman JA, Allen CT, Madtes DK, Schramm J, Delaney C. Pulmonary veno-occlusive disease following reduced-intensity cord blood transplantation. Bone Marrow Transplant 42: 559-561, 2008.
15. Hackman RC, Madtes DK, Petersen FB, Clark JG. Pulmonary venoocclusive disease following bone marrow transplantation. Transplantation 47: 989-992, 1989.
16. Frazier AA, Franks TJ, Mohammed TL, Ozbudak IH, Galvin JR. From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. Radiographics 27: 867-882, 2007.